Acacia Research Corp

ACTG remains in a Stage 4 decline with a medium-term bearish bias reinforced by the Bearish Pivot Point pattern and lower highs under the 50-day SMA. Short-term conditions are neutral, as price holds just below flattening 9/20/50 EMAs without clear momentum. We will look to sell into rebounds toward those EMAs and the 50-day SMA, aiming for rejection-based entries. The long-term uptrend above the 200-day SMA persists, providing structural support but not overriding current downtrend pressures.

• ↑Q2 revenue $114.6M (+124% YoY) driven by acquisitions
• ↑$334.6M cash on hand, no parent debt enables opportunistic M&A
• ↓Licensing rev variability; $3.7M legal costs strain cash flow